long term risks of tirzepatide Side Effects: Timeline, Symptoms, Weight Regain & Long-Term Safety Long-Term Safety of Tirzepatide (Mounjaro):

Important safety information: Mounjaro (tirzepatide) is a prescription-only medication for treating type 2 diabetes and managing obesity

Many patients notice appetite changes and early weight loss within 48 weeks , with more significant results seen over 36 months

When Mounjaro launched in the UK in 2024, it was priced lower than in other European markets to support faster access

If you suspect you have experienced a side effect from Rybelsus, you can report this through the MHRA Yellow Card scheme

Patients with certain GLP1R variants often show steeper blood pressure reductions, suggesting earlier conversations about dose tapering of antihypertensive agents

Physiologically, your body undergoes several adaptations as you lose weight